Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 May;22(3):147-54.

Chronic actinic dermatitis: an analysis at a single institution over 25 years

Affiliations
  • PMID: 21569744

Chronic actinic dermatitis: an analysis at a single institution over 25 years

Syril K Que et al. Dermatitis. 2011 May.

Abstract

Background: Chronic actinic dermatitis (CAD) is a rare photosensitivity disorder with scant epidemiologic data.

Objective: To evaluate demographic data and results of photopatch and patch tests over a 25-year period.

Methods: Retrospective chart review of patients with CAD from 1993 to 2009.

Results: Forty patients had a mean age of 57.8 years, and 27 (67.5%) were men. Twelve patients (30%) were skin types I and II, and 17 (42.5%) were skin types V and VI. Nine patients (22.5%) were younger than 50 years, and 4 of these (44.4%) were men. One of the nine patients (11.1%) was skin type I, and 4 (44.4%) were skin types V and VI. Carba mix and para-phenylenediamine were the two most commonly positive agents in patch tests. Sunscreens and plants and plant derivatives were the most commonly positive agents in photopatch tests.

Conclusions: Our findings suggest a trend of two new classes of North American patients at our institution being diagnosed with CAD-younger women with skin types IV to VI and older men with skin types I to III. We observed a greater-than-expected number of positive patch-test reactions to para-phenylenediamine. We suggest that patch testing and photopatch testing of individuals may be useful adjuncts in the assessment of CAD.

PubMed Disclaimer

LinkOut - more resources